SCHEMBL13702963

SCHEMBL13702963

c1cc2c(cc1C1CCCC1)c1c3n2CCNC3CCC1

nearest known ligand 0.98

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.98
MEN1 O00255 7/20 0.98
MAPT P10636 7/20 0.98
ALDH1A1 P00352 6/20 0.98
TP53 P04637 4/20 0.98
MAPK1 P28482 4/20 0.98
CYP1A2 P05177 3/20 0.98
CYP2D6 P10635 3/20 0.98
TDP1 Q9NUW8 3/20 0.98
CYP3A4 P08684 2/20 0.98
CYP2C9 P11712 1/20 0.98
CYP2C19 P33261 1/20 0.98
LMNA P02545 4/20 0.85
NPSR1 Q6W5P4 3/20 0.85
CCR6 P51684 2/20 0.85
HSD17B10 Q99714 7/20 0.70
KDM4E B2RXH2 7/20 0.70
GAA P10253 4/20 0.70
HTR1A P08908 1/20 0.70
ADRA2A P08913 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2509281 0.99 KMT2A (1.00) KMT2AMEN1MAPTALDH1A1TP53
Hydrochloric Acid SCHEMBL9849090 0.98 KMT2A (0.98) KMT2AMEN1MAPTALDH1A1TP53
Pirlindole SCHEMBL29500947 0.82 HSD17B10 (1.00) KMT2AMEN1MAPTALDH1A1TP53
Pirlindole SCHEMBL18878061 0.82 HSD17B10 (1.00) KMT2AMEN1MAPTALDH1A1TP53
Pirlindole SCHEMBL373564 0.82 HSD17B10 (1.00) KMT2AMEN1MAPTALDH1A1TP53
Pirlindole SCHEMBL18877133 0.82 HSD17B10 (1.00) KMT2AMEN1MAPTALDH1A1TP53
SCHEMBL12922443 0.82 KMT2A (0.68) KMT2AMEN1MAPTALDH1A1TP53
Pirlindole SCHEMBL4157397 0.81 HSD17B10 (0.97) KMT2AMEN1MAPTALDH1A1TP53
Pirlindole SCHEMBL1649683 0.81 HSD17B10 (0.95) KMT2AMEN1MAPTALDH1A1TP53
SCHEMBL3174932 0.79 HSD17B10 (0.97) KMT2AMEN1MAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9980942-B2 Rejuvenation of precursor cells CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2018-05-29 US disclosed
US-9433663-B2 Mobilization of hematopoietic stem cells CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2016-09-06 US disclosed
US-20150297563-A1 REJUVENATION OF PRECURSOR CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-22 US disclosed
WO-2013166043-A1 REJUVENATION OF PRECURSOR CELLS CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2013-11-07 WO disclosed
US-20130202553-A1 MOBILIZATION OF HEMATOPOIETIC STEM CELLS CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2013-08-08 US disclosed
WO-2009114725-A2 MOBILIZATION OF HEMATOPOIETIC STEM CELLS CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2009-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130202553-A1 MOBILIZATION OF HEMATOPOIETIC STEM CELLS CDC42, CDC45, CDC42BPG KMT2A 2939/4885MEN1 1827/4885MAPT 4599/4885
US-20150297563-A1 REJUVENATION OF PRECURSOR CELLS CDC42, RAPGEF3, HRAS KMT2A 3614/4885MEN1 3618/4885MAPT 3235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.